Open Access

Upregulation of lncRNA RMRP promotes the activation of cardiac fibroblasts by regulating miR‑613

  • Authors:
    • Shuang‑Yin Zhang
    • Sheng‑Hui Huang
    • Shi‑Xiong Gao
    • Ying‑Bin Wang
    • Ping Jin
    • Feng‑Jiao Lu
  • View Affiliations

  • Published online on: September 2, 2019     https://doi.org/10.3892/mmr.2019.10634
  • Pages: 3849-3857
  • Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Long non‑coding RNAs (lncRNAs) have been reported to serve a key role in a variety of cardiovascular diseases, including in cardiac fibrosis. The present study aimed to investigate the biological role and underlying mechanisms of the induction of cardiac fibroblasts by the lncRNA, RNA component of mitochondrial RNA processing endoribonuclease (RMRP). The results demonstrated that RMRP expression was upregulated in the presence of cardiac fibrosis in an abdominal aortic banding‑treated rat model. Treatment with angiotensin II increased RMRP expression in cardiac fibroblasts, while the knockdown of RMRP by small‑interfering RNA inhibited cardiac fibroblast proliferation, differentiation and collagen accumulation. To further investigate the underlying mechanisms of this interaction, microRNA (miR)‑613 was predicted to be a target miR of RMRP and sequence alignment, luciferase activity and MS2 RNA immunoprecipitation were performed to detect the interaction between RMRP and miR‑613. The results suggested that RMRP negatively regulated miR‑613 in cardiac fibroblasts. Furthermore, miR‑613 was indicated to mediate the promoting effect of RMRP on cardiac fibroblast activation. The current study suggested that RMRP promoted cardiac fibroblast activation by acting as a competing endogenous RNA for miR‑613. Therefore, RMRP may be a novel target for the prevention or treatment of cardiac fibrosis.

References

1 

Gonzalez A, Schelbert EB, Diéz J and Butler J: Myocardial interstitial fibrosis in heart failure: Biological and translational perspectives. J Am Coll Cardiol. 71:1696–1706. 2018. View Article : Google Scholar : PubMed/NCBI

2 

Weber KT, Sun Y, Tyagi SC and Cleutjens JP: Collagen network of the myocardium: Function, structural remodeling and regulatory mechanisms. J Mol Cell Cardiol. 26:279–292. 1994. View Article : Google Scholar : PubMed/NCBI

3 

Hara H, Takeda N and Komuro I: Pathophysiology and therapeutic potential of cardiac fibrosis. Inflamm Regen. 37:132017. View Article : Google Scholar : PubMed/NCBI

4 

Djebali S, Davis CA, Merkel A, Dobin A, Lassmann T, Mortazavi A, Tanzer A, Lagarde J, Lin W, Schlesinger F, et al: Landscape of transcription in human cells. Nature. 489:101–108. 2012. View Article : Google Scholar : PubMed/NCBI

5 

Creemers EE and van Rooij E: Function and therapeutic potential of noncoding RNAs in cardiac fibrosis. Circ Res. 118:108–118. 2016. View Article : Google Scholar : PubMed/NCBI

6 

Hou J, Zhou C, Long H, Zheng S, Guo T, Wu Q, Wu H, Zhong T and Wang T: Long noncoding RNAs: Novel molecules in cardiovascular biology, disease and regeneration. Exp Mol Pathol. 100:493–501. 2016. View Article : Google Scholar : PubMed/NCBI

7 

Rosenbluh J, Nijhawan D, Chen Z, Wong KK, Masutomi K and Hahn WC: RMRP is a non-coding RNA essential for early murine development. PLoS One. 6:e262702011. View Article : Google Scholar : PubMed/NCBI

8 

Meng Q, Ren M, Li Y and Song X: LncRNA-RMRP acts as an oncogene in lung cancer. PLoS One. 11:e01648452016. View Article : Google Scholar : PubMed/NCBI

9 

Shao Y, Ye M, Li Q, Sun W, Ye G, Zhang X, Yang Y, Xiao B and Guo J: LncRNA-RMRP promotes carcinogenesis by acting as a miR-206 sponge and is used as a novel biomarker for gastric cancer. Oncotarget. 7:37812–37824. 2016. View Article : Google Scholar : PubMed/NCBI

10 

Feng W, Li L, Xu X, Jiao Y and Du W: Up-regulation of the long non-coding RNA RMRP contributes to glioma progression and promotes glioma cell proliferation and invasion. Arch Med Sci. 13:1315–1321. 2017. View Article : Google Scholar : PubMed/NCBI

11 

Wang X, Peng L, Gong X, Zhang X, Sun R and Du J: LncRNA-RMRP promotes nucleus pulposus cell proliferation through regulating miR-206 expression. J Cell Mol Med. 22:5468–5476. 2018. View Article : Google Scholar : PubMed/NCBI

12 

Greco S, Zaccagnini G, Perfetti A, Fuschi P, Valaperta R, Voellenkle C, Castelvecchio S, Gaetano C, Finato N, Beltrami AP, et al: Long noncoding RNA dysregulation in ischemic heart failure. J Transl Med. 14:1832016. View Article : Google Scholar : PubMed/NCBI

13 

Steinbusch MMF, Caron MMJ, Surtel DAM, Friedrich F, Lausch E, Pruijn GJM, Verhesen W, Schroen BLM, van Rhijn LW, Zabel B and Welting TJM: Expression of RMRP RNA is regulated in chondrocyte hypertrophy and determines chondrogenic differentiation. Sci Rep. 7:64402017. View Article : Google Scholar : PubMed/NCBI

14 

Cai SA, Hou N, Zhao GJ, Liu XW, He YY, Liu HL, Hua YQ, Li LR, Huang Y, Ou CW, et al: Nrf2 is a key regulator on puerarin preventing cardiac fibrosis and upregulating metabolic enzymes UGT1A1 in rats. Front Pharmacol. 9:5402018. View Article : Google Scholar : PubMed/NCBI

15 

Li WQ, Li XH, Wu YH, Du J, Wang AP, Li D and Li YJ: Role of eukaryotic translation initiation factors 3a in hypoxia-induced right ventricular remodeling of rats. Life Sci. 144:61–68. 2016. View Article : Google Scholar : PubMed/NCBI

16 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI

17 

Chu W, Li C, Qu X, Zhao D, Wang X, Yu X, Cai F, Liang H, Zhang Y, Zhao X, et al: Arsenic-induced interstitial myocardial fibrosis reveals a new insight into drug-induced long QT syndrome. Cardiovasc Res. 96:90–98. 2012. View Article : Google Scholar : PubMed/NCBI

18 

Chacar S, Farés N, Bois P and Faivre JF: Basic signaling in cardiac fibroblasts. J Cell Physiol. 232:725–730. 2017. View Article : Google Scholar : PubMed/NCBI

19 

Porter KE and Turner NA: Cardiac fibroblasts: At the heart of myocardial remodeling. Pharmacol Ther. 123:255–278. 2009. View Article : Google Scholar : PubMed/NCBI

20 

Wu Z, Qi Y, Guo Z, Li P and Zhou D: miR-613 suppresses ischemia-reperfusion-induced cardiomyocyte apoptosis by targeting the programmed cell death 10 gene. Biosci Trends. 10:251–257. 2016. View Article : Google Scholar : PubMed/NCBI

21 

Karakikes I, Chaanine AH, Kang S, Mukete BN, Jeong D, Zhang S, Hajjar RJ and Lebeche D: Therapeutic cardiac-targeted delivery of miR-1 reverses pressure overload-induced cardiac hypertrophy and attenuates pathological remodeling. J Am Heart Assoc. 2:e0000782013. View Article : Google Scholar : PubMed/NCBI

22 

Jathar S, Kumar V, Srivastava J and Tripathi V: Technological developments in lncRNA biology. Adv Exp Med Biol. 1008:283–323. 2017. View Article : Google Scholar : PubMed/NCBI

23 

Deniz E and Erman B: Long noncoding RNA (lincRNA), a new paradigm in gene expression control. Funct Integr Genomics. 17:135–143. 2017. View Article : Google Scholar : PubMed/NCBI

24 

Nebbioso A, Tambaro FP, Dell'Aversana C and Altucci L: Cancer epigenetics: Moving forward. PLoS Genet. 14:e10073622018. View Article : Google Scholar : PubMed/NCBI

25 

Tao H, Zhang JG, Qin RH, Dai C, Shi P, Yang JJ, Deng ZY and Shi KH: LncRNA GAS5 controls cardiac fibroblast activation and fibrosis by targeting miR-21 via PTEN/MMP-2 signaling pathway. Toxicology. 386:11–18. 2017. View Article : Google Scholar : PubMed/NCBI

26 

Qu X, Du Y, Shu Y, Gao M, Sun F, Luo S, Yang T, Zhan L, Yuan Y, Chu W, et al: MIAT is a Pro-fibrotic long Non-coding RNA governing cardiac fibrosis in Post-infarct myocardium. Sci Rep. 7:426572017. View Article : Google Scholar : PubMed/NCBI

27 

Liang H, Pan Z, Zhao X, Liu L, Sun J, Su X, Xu C, Zhou Y, Zhao D, Xu B, et al: LncRNA PFL contributes to cardiac fibrosis by acting as a competing endogenous RNA of let-7d. Theranostics. 8:1180–1194. 2018. View Article : Google Scholar : PubMed/NCBI

28 

Wang X, Yong C, Yu K, Yu R, Zhang R, Yu L, Li S and Cai S: Long noncoding RNA (lncRNA) n379519 promotes cardiac fibrosis in Post-infarct myocardium by targeting miR-30. Med Sci Monit. 24:3958–3965. 2018. View Article : Google Scholar : PubMed/NCBI

29 

Yoon JH, Abdelmohsen K and Gorospe M: Functional interactions among microRNAs and long noncoding RNAs. Semin Cell Dev Biol. 34:9–14. 2014. View Article : Google Scholar : PubMed/NCBI

30 

Huang ZW, Tian LH, Yang B and Guo RM: Long noncoding RNA H19 acts as a competing endogenous RNA to mediate CTGF expression by sponging miR-455 in cardiac fibrosis. DNA Cell Biol. 36:759–766. 2017. View Article : Google Scholar : PubMed/NCBI

31 

Kong F, Jin J, Lv X, Han Y, Liang X, Gao Y and Duan X: Long noncoding RNA RMRP upregulation aggravates myocardial ischemia-reperfusion injury by sponging miR-206 to target ATG3 expression. Biomed Pharmacother. 109:716–725. 2019. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

October 2019
Volume 20 Issue 4

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Zhang, S., Huang, S., Gao, S., Wang, Y., Jin, P., & Lu, F. (2019). Upregulation of lncRNA RMRP promotes the activation of cardiac fibroblasts by regulating miR‑613. Molecular Medicine Reports, 20, 3849-3857. https://doi.org/10.3892/mmr.2019.10634
MLA
Zhang, S., Huang, S., Gao, S., Wang, Y., Jin, P., Lu, F."Upregulation of lncRNA RMRP promotes the activation of cardiac fibroblasts by regulating miR‑613". Molecular Medicine Reports 20.4 (2019): 3849-3857.
Chicago
Zhang, S., Huang, S., Gao, S., Wang, Y., Jin, P., Lu, F."Upregulation of lncRNA RMRP promotes the activation of cardiac fibroblasts by regulating miR‑613". Molecular Medicine Reports 20, no. 4 (2019): 3849-3857. https://doi.org/10.3892/mmr.2019.10634